[Liver hemosiderosis in chronic hepatitis]

O A Smirnov1, N M Anichkov, V G Radchenko

  • 1I.M. Mechnikov Saint-Petersburg State Medical Academy, 195067, Saint-Petersburg.

Arkhiv Patologii
|April 3, 2003
PubMed

Insights

Liver hemosiderosis, a marker of iron overload, is common in chronic hepatitis B, C, and alcoholic liver disease. Its presence is linked to more severe disease and reduced treatment effectiveness.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Context:

  • Liver hemosiderosis (LH) is a condition indicating organ iron overload.
  • Chronic hepatitis (CH) encompasses viral (B, C) and alcoholic (AL) etiologies.
  • Understanding LH prevalence and associations is crucial for patient management.

Purpose:

  • To investigate the incidence and clinical associations of liver hemosiderosis in patients with chronic hepatitis.
  • To evaluate the impact of LH on disease severity and treatment efficacy.

Summary:

  • Liver hemosiderosis was present in 39.4% of patients with chronic hepatitis (B, C, or AL).
  • Incidence rates were 33.3% in CH B, 49.3% in CH C, and 48.7% in AL.
  • LH correlated with longer disease duration, higher activity, and advanced hepatic cirrhosis.

Impact:

  • Liver hemosiderosis is associated with more severe chronic hepatitis and alcoholic liver disease.
  • Reaferon therapy showed reduced efficacy in hepatitis B and C patients with LH.
  • These findings highlight LH as secondary hemosiderosis, impacting therapeutic outcomes.

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Liver Histology01:27

Liver Histology

The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...